Evidence map›Paper›PMID 33457596›Full record

ArticleJournal of patient experience2020

Patient Perspective on the Management of Cancer Pain in Spain.

Jesús García-Foncillas, Antonio Antón-Torres, Fernando Caballero-Martínez, Francisco J Campos, Margarita Feyjoo, Alfonso Gómez de Liaño, Diana Monge, Carlos Camps

Abstract read
In one paragraph

Article in Journal of patient experience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jesús García-FoncillasServicio de Oncología Médica, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.ORCID https://orcid.org/0000-0002-7591-8006
Antonio Antón-TorresFundación ECO, Madrid, Spain.
Fernando Caballero-MartínezFacultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.
Francisco J CamposFacultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.
Margarita FeyjooFundación ECO, Madrid, Spain.
Alfonso Gómez de LiañoServicio de Oncología Médica, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain.ORCID https://orcid.org/0000-0002-1844-8474
Diana MongeFacultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.ORCID https://orcid.org/0000-0002-3593-1820
Carlos CampsFundación ECO, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain in cancer is often underdiagnosed and undertreated. Breakthrough pain, in particular, severely impacts the quality of life of patients. In this study, we evaluated management and care of pain in Spain from the patient perspective by assessing the experience of 275 patients who had suffered breakthrough pain. Although most patients had suffered moderate-to-severe pain in the last 24 hours, pain relief was achieved in the majority of cases. The body areas with a higher pain intensity was felt varied based on primary cancer. Adherence to treatment was subpar, and patients were moderately concerned about addiction to treatment and adverse events. Doctors did not assess pain in every visit and there is room for improvement in its classification. Education strategies directed toward patients and health care personnel are needed to improve pain assessment, follow-up, and compliance. These could guide shared decision-making and improve communication about cancer pain to improve its care.

Indexed as

breakthrough paincancer painchronic painpatient experienceSpain

Identifiers

PMID33457596
PMCPMC7786723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.